News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
829,025 Results
Type
Article (85517)
Company Profile (743)
Press Release (742765)
Section
Business (232206)
Career Advice (4100)
Deals (39639)
Drug Delivery (113)
Drug Development (90618)
Employer Resources (194)
FDA (17973)
Job Trends (17264)
News (395493)
Policy (39613)
Tag
Academia (2975)
Alliances (56406)
Alzheimer's disease (1322)
Approvals (17868)
Artificial intelligence (137)
Bankruptcy (394)
Best Places to Work (12445)
Biotechnology (506)
Breast cancer (114)
Cancer (980)
Cardiovascular disease (90)
Career advice (3509)
Cell therapy (227)
Clinical research (71188)
Collaboration (350)
Compensation (174)
COVID-19 (2793)
Data (876)
Diabetes (147)
Diagnostics (6633)
Drug pricing (101)
Earnings (94027)
Employer resources (167)
Events (126056)
Executive appointments (254)
FDA (18430)
Funding (308)
Gene therapy (171)
GLP-1 (674)
Government (5039)
Healthcare (20695)
Infectious disease (2875)
Inflammatory bowel disease (114)
Interviews (807)
IPO (17558)
Job creations (5177)
Job search strategy (2853)
Layoffs (483)
Legal (10037)
Lung cancer (171)
Manufacturing (174)
Medical device (14382)
Medtech (14387)
Mergers & acquisitions (22062)
Metabolic disorders (421)
Neuroscience (1589)
NextGen Class of 2024 (7653)
Non-profit (5062)
Northern California (1220)
Obesity (248)
Opinion (241)
Patents (103)
People (64011)
Pharmaceutical (146)
Phase I (21881)
Phase II (30901)
Phase III (23328)
Pipeline (212)
Postmarket research (3539)
Preclinical (9886)
Radiopharmaceuticals (256)
Rare diseases (202)
Real estate (7371)
Regulatory (25869)
Research institute (2640)
Resumes & cover letters (648)
Southern California (1109)
Startups (4274)
United States (12587)
Vaccines (637)
Weight loss (208)
Date
Today (83)
Last 7 days (765)
Last 30 days (2985)
Last 365 days (38477)
2024 (32692)
2023 (42566)
2022 (53928)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37192)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Arizona (222)
Asia (49227)
Australia (8672)
California (2880)
Canada (1184)
China (220)
Colorado (128)
Connecticut (137)
Europe (112698)
Florida (401)
Georgia (109)
Illinois (382)
Indiana (196)
Kansas (102)
Maryland (563)
Massachusetts (2413)
Michigan (160)
Minnesota (271)
New Jersey (863)
New York (868)
North Carolina (795)
Northern California (1220)
Ohio (133)
Pennsylvania (761)
South America (1647)
Southern California (1109)
Texas (421)
Washington State (358)
There are 829,025 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Breast Cancer Liquid Biopsy Market Size to Hit USD 2.89 Billion by 2034
November 4, 2024
·
1 min read
GLP-1
Novo Nordisk Signs $285M GLP-1 Deal With Danish Neighbor Ascendis
In a deal worth up to $285 million initially for the lead program, Novo Nordisk will gain access to Ascendis’ TransCon technology platform in an effort to find novel GLP-1 candidates with reduced dosing frequency.
November 4, 2024
·
1 min read
·
Annalee Armstrong
Earnings
BioNTech Handily Beats Q3 Expectations, Trims Full-Year Revenue Guidance
Driven by the early approval of its updated COVID-19 vaccine, BioNTech far exceeded analysts’ expectations in the third quarter and reported its first quarterly profit in 2024. However, the German biotech also cut its outlook for the year.
November 4, 2024
·
3 min read
·
Tristan Manalac
Press Releases
DNA Methylation Market Size to Hit USD 6.26 Billion by 2034
November 4, 2024
·
1 min read
Layoff Tracker
Sage’s Employee Cuts Include 69 in Cambridge
Follow along as
BioSpace
keeps you up-to-date on the latest pharma and biotech layoffs.
November 4, 2024
·
174 min read
·
BioSpace Editorial Staff
FDA Tracker
Journey Medical Nets Rosacea Approval
In 2023, the FDA greenlit 55 new drugs and 34 cell and gene therapies. Follow along as
BioSpace
keeps you up to date on all of the FDA’s decisions in 2024.
November 4, 2024
·
197 min read
·
Heather McKenzie
CAR T
CAR T and Related Therapies Home In on Autoimmune Disease
Multiple players are exploring whether modalities designed to combat B cell malignancies can be repurposed against lupus, myasthenia gravis and other conditions traced to misdirected immune response.
November 4, 2024
·
9 min read
·
Shawna Williams
Drug pricing
AstraZeneca, BMS, J&J Renew Legal Challenge to IRA Before Appeals Court
The Big Pharma companies made a last-ditch effort asking a U.S. appeals court to reconsider their lawsuits against the Inflation Reduction Act’s Medicare drug price negotiations, which they contend infringe on their constitutional rights.
November 4, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Oak Hill Bio and Chiesi Group Announce First European Patient Enrolled in the Phase 2b Clinical Study Evaluating OHB-607 for the Prevention of Bronchopulmonary Dysplasia, the Most Common Cause of Chronic Lung Disease in Premature Infants
November 4, 2024
·
7 min read
Press Releases
OBIO® and CATTI Collaborate to Boost Canada’s Biomanufacturing Capacity for Advanced Therapies
November 4, 2024
·
3 min read
1 of 82,903
Next
